Avocado and Mango Trial Shows Measurable Vascular Gains in Prediabetes

Cardiovascular risk management often defaults to broad elimination lists: less sodium, fewer refined carbohydrates, stripped-down plates. A clinical trial examining adults with prediabetes shifts that emphasis by testing targeted additions. Over an eight-week intervention, participants who consumed one whole avocado and one cup of fresh mango daily demonstrated significant improvements in endothelial function and diastolic blood pressure, without altering their total caloric intake or gaining body weight.

The vascular changes were pronounced in male participants, who showed marked reductions in peripheral arterial stiffness. The biological mechanism centers on the simultaneous delivery of monounsaturated fats from avocado, which support lipid transport, alongside specific polyphenols and potassium from mango. Rather than spiking glucose, the combination improved microvascular responsiveness, measured via flow-mediated dilation.

Rather than waiting for an automated coaching interface to recommend another generic Mediterranean plate, you can use these parameters directly. If you track resting blood pressure and arterial wave velocity at home, introducing this specific whole-food pairing across an eight-week block gives you a clear baseline to assess your own vascular responsiveness.